Manish Baviskar, Hubot CDMO, explains which AI skills validation engineers need first and why AI model updates must go ...
Ron Filler, Drug Development Consultants, explains how USP's 1074 revision brings human-relevant safety science to ...
Aleksandra Zuraw, senior veterinary pathologist at Charles River, discusses how chain of custody, good laboratory practice, ...
Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and ...
Bill Williams, AAPS, compares KinetiSol and spray drying for amorphous solid dispersions, covering 75% drug loading, pill ...
Nitin Kumar Swarnakar, PhD, global application lab manager at BASF in Tarrytown, spoke with PharmTech at AAPS PharmSci 360 ...
Pauric Bannigan, Intrepid Labs, explains how physics-informed machine learning aids formulation and why regulators still want ...
Vibha Jawa, PhD, chief scientific officer at EpiVax, explains why the need for animal studies varies by modality and what it ...
PharmTech spoke with Pauric Bannigan, chief scientific officer and co-founder, Intrepid Labs, at AAPS PharmSci 360 2026, ...
Sanjay Konagurthu, PhD, senior director of Science and Innovation at Thermo Fisher Scientific, spoke with PharmTech at AAPS ...
FDA draft guidance on individualized genome editing lets BLAs add patient-specific variants without new trials, shifting evidence to CMC assay data.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results